Debridement — the removal of necrotic, devitalized, or contaminated tissue from a wound — is one of the most fundamental and best-studied interventions in diabetic foot ulcer (DFU) care. Chronic DFUs accumulate slough, eschar, biofilm, and senescent cells that physically and biochemically block re-epithelialization. Clearing this material restores a viable wound bed, reduces bacterial burden, and re-exposes growth factors that drive healing. Although the principle is straightforward, the choice of technique, the frequency of debridement, and the strength of evidence behind each method vary considerably. The 2023 update from the International Working Group on the Diabetic Foot (IWGDF) offers the clearest current framework for clinicians.
Why Debridement Matters in the Diabetic Foot
In a diabetic foot ulcer, the wound bed is typically populated by hyperkeratotic callus, fibrinous slough, bacterial biofilm, and matrix metalloproteinase-rich exudate. Removing this material converts a stalled chronic wound into a more acute-appearing wound capable of progressing through the normal healing trajectory. A large retrospective cohort of more than 300,000 wounds first demonstrated that more frequent debridement was strongly associated with shorter time to healing, an observation that has since shaped clinical practice worldwide (Wilcox et al., 2013). Subsequent randomized and observational data in DFUs have continued to support debridement as the cornerstone of local wound care (Lazaro-Martinez et al., 2022).
The Major Debridement Techniques
Sharp and Surgical Debridement
Sharp debridement, performed at the bedside with a scalpel, curette, or scissors, and surgical debridement performed in the operating room, are the most rapid and selective methods. They permit precise removal of nonviable tissue while preserving healthy tissue and allow direct inspection of the wound base, including probe-to-bone testing. The IWGDF 2023 wound-healing guideline recommends sharp/surgical debridement as the preferred technique because it is the most widely available, the fastest, and the most consistently supported by the evidence base in DFUs (Chen et al., 2024).
Autolytic Debridement
Autolytic debridement uses occlusive or semi-occlusive dressings — hydrogels, hydrocolloids, or films — to maintain a moist wound environment that allows endogenous enzymes and macrophages to digest devitalized tissue. It is painless and selective but slow. Systematic reviews suggest low-to-moderate evidence of benefit when sharp debridement is not feasible, but the IWGDF 2023 guideline does not recommend autolytic debridement as a substitute for sharp debridement in DFUs (Chen et al., 2024).
Enzymatic Debridement
Enzymatic agents such as collagenase chemically degrade necrotic tissue. Network meta-analytic data suggest enzymatic debridement can produce meaningful wound-area reduction, particularly in settings where sharp debridement is difficult to perform regularly (Ning et al., 2023). However, the IWGDF does not recommend its routine use over standard sharp debridement, citing limited high-quality comparative evidence in the diabetic foot.
Biosurgical (Larval) Debridement
Maggot debridement therapy uses sterile Lucilia sericata larvae to selectively digest necrotic tissue and reduce bacterial burden, including resistant organisms. Small clinical studies in non-healing DFUs have reported high rates of wound-bed preparation and complete healing in selected patients (Siavash et al., 2021). The IWGDF 2023 guideline concluded that no randomized controlled trials in DFUs met their pre-specified inclusion criteria and therefore did not issue a recommendation for routine use (Chen et al., 2024).
Ultrasonic and Hydrosurgical Debridement
Low-frequency contact ultrasound and high-pressure hydrosurgical systems offer selective tissue removal with potential biofilm disruption. A 2022 systematic review and meta-analysis of ultrasound-assisted debridement in DFUs reported improved wound-area reduction and healing rates compared with standard care (Chang et al., 2022). Despite these signals, the IWGDF 2023 guideline does not recommend ultrasonic or hydrosurgical debridement over standard sharp debridement, citing inconsistent trial quality.
How Often Should DFUs Be Debrided?
Frequency has long been considered as important as technique. Although older cohort data suggested that weekly or more frequent debridement produced the fastest healing, a 2021 multicenter randomized trial directly comparing weekly with every-second-week sharp debridement in DFUs found no significant difference in healing rates at 12 weeks (Manu et al., 2021). The implication is that debridement intervals can be tailored to the individual wound and to clinic resources, provided that callus and slough are not allowed to accumulate.
Clinical Summary
Debridement remains a cornerstone of diabetic foot ulcer care. Current evidence and the 2023 IWGDF wound-healing guideline support sharp or surgical debridement as the preferred technique, with other modalities — autolytic, enzymatic, biosurgical, ultrasonic, and hydrosurgical — reserved for circumstances in which sharp debridement is not feasible or as adjuncts in selected patients. Recent randomized data suggest that the interval between debridements can be individualized without compromising healing. As with all DFU care, debridement should occur within a comprehensive program that includes offloading, infection control, vascular assessment, and glycemic management.
References
Chen P, Vilorio NC, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3644.
Manu C, Lacopi E, Bouillet B, et al. A Randomized Trial Comparing Weekly With Every Second Week Sharp Debridement in People With Diabetes-Related Foot Ulcers Shows Similar Healing Outcomes: Potential Benefit to Resource Utilization. Diabetes Care. 2021;44(12):e203-e205.
Ning F, Liu W, Kang T, Cao Y, Zhang B. Comparison of healing effectiveness of different debridement approaches for diabetic foot ulcers: a network meta-analysis of randomized controlled trials. Frontiers in Public Health. 2023;11:1271706.
Chang YJ, Hsu CM, Lin CH, Lu MS, Chen L. Ultrasound-Assisted Wound (UAW) Debridement in the Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(7):1933.
Siavash M, Najjarnezhad A, Mohseni N, et al. Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study. The International Journal of Lower Extremity Wounds. 2021;20(2):109-115.
Lazaro-Martinez JL, Garcia-Madrid M, Garcia-Alvarez Y, et al. Debridement of Diabetic Foot Ulcers: Public Health and Clinical Implications — A Systematic Review, Meta-Analysis, and Meta-Regression. BMJ Open Diabetes Research & Care. 2022;10(2):e002730.
Wilcox JR, Carter MJ, Covington S. Frequency of Debridements and Time to Heal: A Retrospective Cohort Study of 312,744 Wounds. JAMA Dermatology. 2013;149(9):1050-1058.
Comments
